Travere Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Travere Therapeutics by Assenagon Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $19M | 1.4M | 13.99 |
2024-06-30 | $18M | 2.2M | 8.22 |
2024-03-31 | $1.7M | 219k | 7.71 |
2023-12-31 | $2.3M | 254k | 8.99 |
2023-09-30 | $2.3M | 254k | 8.94 |
2023-06-30 | $17M | 1.1M | 15.36 |
2023-03-31 | $37M | 1.7M | 22.49 |
2022-12-31 | $18M | 867k | 21.03 |
2022-09-30 | $23M | 925k | 24.64 |
2022-06-30 | $23M | 951k | 24.23 |
2022-03-31 | $8.0M | 311k | 25.77 |
2021-12-31 | $6.1M | 196k | 31.04 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management